Not finding it? Sign in to also search OpenAlex live.
-
AXSANA (AXillary Surgery After NeoAdjuvant Treatment): A European prospective multicenter cohort study to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy2020 Senologie - Zeitschrift für Mammadiagnostik und -therapie conference-paper Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Maggie Banys‐Paluchowski, Elmar Stickeler, Jana de Boniface, Oreste Gentilini, Marc Thill, Steffi Hartmann, +6 more
1citations -
Clinical, Radiologic, and Functional Outcomes Following Methotrexate Withdrawal in Etanercept-Treated Patients with Active Early Rheumatoid Arthritis: A Subanalysis of COMET Year 2 by Week 52 DAS28 Status2021 The Open Rheumatology Journal article Medicine Rheumatoid Arthritis Research and Therapies Open access
Paul Emery, Ferdinand C. Breedveld, Eduardo Campos‐Alberto, Annette E. Szumski, Tomohiro Hirose
1citations -
Safety and efficacy of combined melphalan percutaneous hepatic perfusion (M-PHP) and ipilimumab plus nivolumab (IPI+NIVO) in metastasized uveal melanoma (mUM): First results of the phase Ib part of the CHOPIN trial.
Thaïs M. L. Tong, Mark Christiaan Burgmans, Frank M. Speetjens, Arian R. van Erkel, Rutger W. van der Meer, Carla S. P. van Rijswijk, +9 more
1citations -
Data from Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors
Giuseppe Curigliano, Hans A. J. Gelderblom, Nicolas Mach, Toshihiko Doi, David Wai-Meng Tai, Patrick M. Forde, +13 more
0citations -
AXSANA (Axillary Surgery After Neoadjuvant Treatment): A European prospective multicenter cohort study to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy: preliminary data2021 Senologie - Zeitschrift für Mammadiagnostik und -therapie conference-paper Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Maggie Banys‐Paluchowski, Elmar Stickeler, Jana de Boniface, Oreste Gentilini, Sarah Fröhlich, M Thill, +18 more
0citations -
Phase Ib/randomized phase II study combining hepatic percutaneous perfusion with ipilimumab plus nivolumab in advanced uveal melanoma: The CHOPIN trial.
Thaïs M. L. Tong, Mark Christiaan Burgmans, Monique K. van der Kooij, Frank M. Speetjens, Arian R. van Erkel, Rutger W. van der Meer, +11 more
0citations -
Peer Review Report For: An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol [version 1; peer review: 2 approved]
Alejandro Krolewiecki, Wendemagegn Enbiale, Javier Gandasegui, Lisette van Lieshout, Stella Kepha, Augusto Messa, +15 more
0citations -
POS0155 CHOICE AND EFFECTIVENESS OF SECOND DMARDS AFTER MTX: COMPARING BIOLOGICAL, TARGETED, AND CONVENTIONAL OPTIONS IN EUROPEAN RA COHORTS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
D. Di Giuseppe, Nils Steinz, J. Sexton, C.A. Hana, H. Lechner-Radner, Daniela Sieghart, +3 more
0citations -
Abstract OT-04-02: The AXSANA trial (AXillary Surgery After NeoAdjuvant treatment): An international prospective multicenter cohort study of the EUBREAST study group to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (NCT04373655)2021 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Maggie Banys‐Paluchowski, Elmar Stickeler, Jana de Boniface, Oreste Gentilini, Marc Thill, Steffi Hartmann, +6 more
0citations -
Peer Review Report For: An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol [version 1; peer review: 2 approved]
Alejandro Krolewiecki, Wendemagegn Enbiale, Javier Gandasegui, Lisette van Lieshout, Stella Kepha, Augusto Messa, +15 more
0citations -
Safety and Preliminary Efficacy Results of a Novel Mesenchymal Stromal Cell Therapy in Diabetic Kidney Disease: The Multicenter, Randomized, Placebo-Controlled, Phase-1b/2a NEPHSTROM Clinical Trial2022 Journal of the American Society of Nephrology conference-abstract Medicine Mesenchymal stem cell research
Matthew Dallas Griffin, Giuseppe Remuzzi, Paul Cockwell, Alexander Peter Maxwell, Norberto Perico, Piero Luigi Ruggenenti, +6 more
0citations -
AXSANA (AXillary Surgery After NeoAdjuvant Treatment): A European prospective multicenter cohort study to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy2020 Geburtshilfe und Frauenheilkunde conference-paper Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Maggie Banys‐Paluchowski, Elmar Stickeler, Jana de Boniface, Oreste Gentilini, Marc Thill, Steffi Hartmann, +6 more
0citations -
AXSANA – AXillary Surgery After NeoAdjuvant Treatment (EUBREAST-3): current status of the international prospective multicenter cohort study evaluating different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (NCT04373655)2022 Senologie - Zeitschrift für Mammadiagnostik und -therapie article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
S. Fröhlich, Malgorzata Joanna Banys-Paluchowski, Elmar Stickeler, Jana de Boniface, Oreste Gentilini, Franziska Ruf, +24 more
0citations -
Data from Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors
Giuseppe Curigliano, Hans A. J. Gelderblom, Nicolas Mach, Toshihiko Doi, David Wai-Meng Tai, Patrick M. Forde, +13 more
0citations